Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-20-049790
Filing Date
2020-04-22
Accepted
2020-04-22 17:28:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B4 tm2012395-5_424b4.htm 424B4 454147
2 GRAPHIC lg_cyclacelreg-4c.jpg GRAPHIC 270388
  Complete submission text file 0001104659-20-049790.txt   808665
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-237180 | Film No.: 20808657
SIC: 2834 Pharmaceutical Preparations